Medicare AdvantageCoverageMedium impact
MA08.004x, Coagulation Factors
Independence Blue Cross·Hematology, Oncology, Pediatrics +1 more·Medical Policy
Effective date
Apr 1, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA08.004x for Coagulation Factors has been updated with changes effective April 1, 2025. This policy likely affects coverage criteria, prior authorization requirements, or billing procedures for coagulation factor treatments and related hemophilia/bleeding disorder services.
Action Required
By April 1, 2025: Billing team must review the complete MA08.004x Coagulation Factors policy at the provided URL to identify specific changes to coverage criteria, prior authorization requirements, or documentation needs for coagulation factor treatments. Update billing procedures and staff training accordingly for Medicare Advantage patients requiring these services.